TLSI
TriSalus Life SciencesFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
TLSI vs peer average
28/100
TLSI vs. peer average (F vs. D)
Grade spread
A 2 · B 1 · C 1 · D 1 · F 5
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
GALT is the first available peer comparator.
Loose small-cap biotech comparator with liver-disease focus and event sensitivity, but not a PEDD/device-commercialization analogue; useful mainly for judging how clinical-readout and financing risk can dominate valuation at this cap range.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
TLSI
TriSalus Life Sciences
GALT
Galectin Therapeutics
Grade
F
C
Momentum
66
96
Value
41
41
Sentiment
20
55
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs GALT
TLSI / GALT
Grade Position
Below peers
TLSI vs. peer average (F vs. D)
28/100
Momentum
66
GALTValue
41
TLSISentiment
20
GALTRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs TLSI
GALT is the first peer returned for this comparison set.